The Science of Photobiomodulation
Empowering Recovery Through Clinical Precision
Photobiomodulation (PBM) is a non-invasive, evidence-based technology that utilizes specific wavelengths of light to stimulate cellular repair and regeneration. At SoLá Pelvic Therapy, we integrate this clinical approach to address the complex physiological needs of the pelvic region with targeted precision.
Our protocol is grounded in real-world evidence (RWE) and is validated by the results of the multicenter sham-control VOICE RCT. We provide a safe, single-therapy solution that is both compassionate and supported by clinical evidence.
Why SoLá Succeeds Where Others Fail
For more than a decade, we have focused on one problem: chronic pelvic pain in women. We have succeeded where others have failed, we are not just effective, we are more effective than sham. SoLá Pelvic Therapy has not been evaluated or cleared by the FDA for the treatment of CPP or other disease or disorder. SoLá Pelvic Therapy is presently available only through an IRB-approved registry at specific clinics across the United States.
Built on Real-World Evidence and VOICE RCT Validation
Our protocol is grounded in over 10,000 real-world treatments and is further validated by the VOICE randomized, sham-controlled trial, designed to rigorously assess efficacy, safety, and patient satisfaction in women with chronic pelvic pain.
Deep, Non-Thermal PBM Where Others Can’t Reach
We utilize a patent-protected method of delivering transvaginal near-infrared energy (photobiomodulation, PBM) with a high-power class IV laser with minimal changes in temperature* allowing the non-thermal mechanisms of PBM to exert therapeutic effects deep inside the pelvis safely.
*Demonstrated safety in animal and human studies. Over 10,000 treatments administered in real clinical settings without a thermal injury.
Why Conventional Lasers Fall Short
Near-infrared photobiomodulation (PBM) is known to reduce prostaglandin production, decrease painful nerve conduction, improve blood flow to oxygen-deprived tissues, and relax hypertonic muscles. However, standard low-powered lasers cannot deliver enough energy to the deep pelvic floor muscles and pelvic organs, limiting their impact where it matters most.
Muscle Relaxation
Specifically targeted to relax hypertonic pelvic floor muscles, reducing myofascial tension that contributes to dyspareunia and pelvic dysfunction.
PBM Deep Tissue Bio-Stimulation
Near-infrared photobiomodulation operates on a cellular level by interacting with mitochondrial chromophores. This non-thermal mechanism triggers a cascade of biological responses that restore homeostasis within the pelvic microenvironment, addressing chronic pain at its physiological root.
Nerve Modulation
Clinical application decreases painful nerve conduction velocities, providing rapid relief for neuropathic pelvic pain symptoms.
Prostaglandin Inhibition
PBM significantly reduces the production of pro-inflammatory prostaglandins, mitigating the chemical triggers of chronic pelvic pain and inflammation.
Microcirculation
Enhancing blood flow to oxygen-deprived deep pelvic tissues promotes metabolic waste removal and accelerates tissue regeneration.
Stepwise Clinical Delivery
Treatment Protocol
01
Patient Selection
Identify clinical candidates based on a diagnosis of chronic pelvic pain. Use standardized pelvic pain assessment tools. Screening includes single-digit pelvic examination of the pelvic muscles for tenderness and or hypertonicity.
02
Utilizing the single-use sterile SoLá transvaginal probe (2 cm diameter), deliver controlled near-infrared energy. Treatment time and power settings are calculated by the laser based on vaginal length and therapeutic power density calculations.
Session Parameters
03
Frequency
Recommended protocol consists of a series of treatments performed optimally over a 4-8 week time frame.
04
Clinical Follow-up
The laser collects patient reported pain scores and displays a graphical representation of their symptoms over time. Each clinician may utilize the graphic for patient education and treatment follow-up decisions.